A thoughtful and defensible valuation is core to any capital raise or acquisition. The Viridian team has extensive experience in and knowledge of the evolving dynamics and the competitive landscape within the cannabis industry. Utilizing data partnerships with leading providers such as BDS Analytics and Marijuana Business Daily in conjunction with our technical expertise provides a valuation that brings comfort to investors and acquirers.

We utilize multiple methodologies that triangulate a valuation defensible to the most sophisticated capital sources. These methodologies include discounted cash flow (DCF) as well as comparable, leveraged buyout (LBO), and precedent transaction analyses.

Viridian’s proprietary Cannabis Deal Tracker provides us with current information on valuations from both public and private transactions as well as real-time changes in industry dynamics. Since its inception, our Viridian Cannabis Deal Tracker has sourced and analyzed more than 2,100 capital raises totaling over $24 billion, as well as over 700 M&A transactions, providing to us significant capital markets intelligence around deal terms and structures as well as keeping us apprised of investment and M&A trends across the global cannabis industry.

Cannabis Deal Tracker

Tracking Capital Raise, M&A and IPO Transactions in the Cannabis Industry

Cannabis Deal Tracker

Tracking Capital Raise, M&A and IPO Transactions in the Cannabis Industry